Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência.
Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
UK’s Prime Minister Theresa May has announced plans to fight prostate cancer with additional funding and research efforts. May’s announcement was made while visiting a Cambridgeshire hospital for a National Health Service ... Read more
Do prostate cancer diagnoses undermine the health of patients’ partners? A team of Danish researchers says “yes.” Led by Jeanne Avlastenok and Peter Østergren from Herlev and Gentofte University Hospital, ... Read more
Kristen Bell, star of the NBC comedy series “The Good Place,” chose the winning stories in the Prostate Cancer Foundation’s first-ever campaign to honor those who care for people with prostate cancer. The TRUE Love ... Read more
More than 150 researchers worldwide will be taking part in a clinical trial on whether exercise can improve prostate cancer symptoms and delay the disease’s progression. The key goal of the Global Action ... Read more
A new patient-partnered initiative aimed at encouraging men with metastatic prostate cancer to collaborate in research has been launched by the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute. ... Read more
Health Canada recently approved Zytiga (abiraterone acetate) in combination with prednisone and androgen deprivation therapy (ADT) for the treatment of patients with newly diagnosed, high-risk metastatic hormone-sensitive prostate cancer (mHSPC) ... Read more